2VAV

ACT: ACETATE ION

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VAV_ACT_D_1384	100%	56%	0.028	0.995	0.82	0.88	-	-	1	0	100%	1
2VAV_ACT_A_1384	100%	51%	0.033	0.993	0.79	1.09	-	-	2	0	100%	1
2VAV_ACT_B_1385	100%	69%	0.033	0.993	0.97	0.25	-	-	1	0	100%	1
2VAV_ACT_I_1384	100%	70%	0.032	0.991	0.93	0.25	-	-	0	0	100%	1
2VAV_ACT_E_1384	100%	48%	0.035	0.992	0.76	1.25	-	-	4	0	100%	1
2VAV_ACT_E_1385	100%	49%	0.037	0.992	0.76	1.2	-	-	0	0	100%	1
2VAV_ACT_I_1385	100%	60%	0.038	0.991	0.97	0.58	-	-	0	0	100%	1
2VAV_ACT_C_1384	100%	49%	0.048	0.996	0.87	1.1	-	-	2	0	100%	1
2VAV_ACT_L_1384	99%	55%	0.051	0.988	0.78	0.96	-	-	0	0	100%	1
2VAV_ACT_F_1384	99%	63%	0.056	0.988	0.84	0.58	-	-	1	0	100%	1
2VAV_ACT_B_1386	99%	50%	0.065	0.992	0.74	1.16	-	-	0	0	100%	1
2VAV_ACT_A_1385	98%	71%	0.064	0.987	0.88	0.26	-	-	0	0	100%	1
2VAV_ACT_I_1386	98%	58%	0.056	0.976	0.83	0.8	-	-	0	0	100%	1
2VAV_ACT_H_1384	97%	56%	0.063	0.979	0.75	0.95	-	-	2	0	100%	1
2VAV_ACT_G_1384	95%	57%	0.069	0.974	0.71	0.95	-	-	1	0	100%	1
2VAX_ACT_I_1385	100%	65%	0.042	0.989	1.04	0.34	-	-	0	0	100%	1
2E7Z_ACT_A_1003	100%	49%	0.021	0.996	0.84	1.11	-	-	0	0	100%	1
3GU3_ACT_A_302	100%	7%	0.023	0.995	1.89	2.92	1	2	0	0	100%	1
3S8J_ACT_A_186	100%	50%	0.021	0.996	1.09	0.84	-	-	8	0	100%	0.8975
5LDS_ACT_B_1012	100%	61%	0.015	0.999	0.83	0.68	-	-	0	0	100%	1
4CQM_ACT_M_501	100%	61%	0.026	0.995	0.75	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.